We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tarloxitinib Puts Tumor-Seeking Tail on Anti-EGFR Drug to Precisely Target Lung Cancer

News   Oct 25, 2017 | Original story written by Garth Sundem for the University of Colorado

 
Tarloxitinib Puts Tumor-Seeking Tail on Anti-EGFR Drug to Precisely Target Lung Cancer
 
 
 

RELATED ARTICLES

Non-circulating T Cells Vital for Protection against Salmonella

News

Noncirculating T cells are relatively unknown, but appear to be a vital component of immunity to Salmonella infection — and should be the focus of vaccine strategies.

READ MORE

3D Microfluidic Platform Enables Neuronal Chemotactic Assays

News

Shedding light on neural regeneration mechanism by recognizing subtle variation in the gradient profiles of guidance molecules.

READ MORE

'Waltzing' Nanoparticles Could Lead to Better Drug Delivery

News

Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE